2 completed, 1 not yet recruiting, 1 recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow PET Scan: new trials by email Literature Review of PET Scan trials Research Report on PET Scan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ga-68 Dolacga PET Scan in HCC Under RFA Ga-68 Dolacga PET scan - Hepatocellular Carcinoma (HCC), Radiofrequency Ablation | Not yet recruiting | National Taiwan University Hospital | 10 | 2025-02-01 | 2025-01-24 | |
| Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment Brentuximab Vedotin for Injection, response-adapted radiation, Doxorubicin - Classical Hodgkin Lymphoma, Child | Phase 2 / Phase 3 | Recruiting | Children's Cancer Group, China | 96 | 2024-09-25 | 2026-03-19 |
| Validation of PET-MRI for Cardiovascular Disease PET/MR scan - MRI, PET Scan | Not applicable | Completed | University of Edinburgh | 20 | 2017-02-09 | 2024-05-21 |
| PET Imaging of Brain mGluR5 Receptors Using [18F]SP203 [18F]SP203 - Healthy, Glutamate Receptor | Phase 1 | Completed | National Institute of Mental Health (NIMH) | 50 | 2007-09-28 | 2018-07-05 |
Carcinoma, Hepatocellular (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Disease (1)
Adenocarcinoma (1) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Carcinoma (1) · Coronary Disease (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Heart Diseases (1) · Liver Diseases (1) · Liver Neoplasms (1) · Myocardial Ischemia (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1)
Brentuximab Vedotin (1) · Cyclophosphamide (1) · Dacarbazine (1) · Doxorubicin (1) · Etoposide (1) · Injections (1) · Prednisone (1) · tislelizumab (1)
Children's Cancer Group, China (1) · National Institute of Mental Health (NIMH) (1) · National Taiwan University Hospital (1) · University of Edinburgh (1)
China (1) · United Kingdom (1) · United States (1)